We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
-$1.98M
Cap. Flow
-$6.75M
Cap. Flow %
-6.58%
Top 10 Hldgs %
34.91%
Holding
723
New
84
Increased
174
Reduced
96
Closed
93

Sector Composition

Rank Sector Weight
1 Miscellaneous 63.01%
2 Financials 7.66%
3 Technology 5.08%
4 Consumer Discretionary 4.96%
5 Healthcare 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
576
lululemon athletica
LULU
$10.6B
$640 ﹤0.01%
2
LCID icon
577
Lucid Motors
LCID
$1.59B
$635 ﹤0.01%
9
SHYG icon
578
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.73B
$613 ﹤0.01%
15
+4
+36% +$164
SWBI icon
579
Smith & Wesson
SWBI
$586M
$607 ﹤0.01%
70
FDIS icon
580
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.6B
$566 ﹤0.01%
10
LYFT icon
581
Lyft
LYFT
$5.94B
$551 ﹤0.01%
50
KD icon
582
Kyndryl
KD
$2.8B
$500 ﹤0.01%
45
TDOC icon
583
Teladoc Health
TDOC
$1.17B
$473 ﹤0.01%
20
BTAL icon
584
AGF US Market Neutral Anti-Beta Fund
BTAL
$313M
$466 ﹤0.01%
+22
New +$456
BCRX icon
585
BioCryst Pharmaceuticals
BCRX
$2.15B
$413 ﹤0.01%
+36
New +$449
CANO
586
DELISTED
Cano Health, Inc.
CANO
$411 ﹤0.01%
3
STT icon
587
State Street
STT
$50.2B
$387 ﹤0.01%
5
XLF icon
588
State Street Financial Select Sector SPDR ETF
XLF
$53.5B
$381 ﹤0.01%
11
-96
-90% -$3.25K
SJB icon
589
ProShares Short High Yield
SJB
$46M
$380 ﹤0.01%
20
ITCI
590
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$370 ﹤0.01%
+7
New +$351
GPRO icon
591
GoPro
GPRO
$262M
$358 ﹤0.01%
72
LNTH icon
592
Lantheus
LNTH
$6.57B
$356 ﹤0.01%
+7
New +$432
SPYG icon
593
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$53.5B
$354 ﹤0.01%
7
EXEL icon
594
Exelixis
EXEL
$14.1B
$352 ﹤0.01%
+22
New +$359
PCRX icon
595
Pacira BioSciences
PCRX
$993M
$347 ﹤0.01%
+9
New +$438
LIN icon
596
Linde
LIN
$213B
$326 ﹤0.01%
1
POSH
597
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$321 ﹤0.01%
18
DCGO icon
598
DocGo
DCGO
$37.7M
$311 ﹤0.01%
44
-6,751
-99% -$56.6K
ICF icon
599
iShares Select U.S. REIT ETF
ICF
$1.95B
$307 ﹤0.01%
6
INVA icon
600
Innoviva
INVA
$1.53B
$304 ﹤0.01%
+23
New +$302

Similar funds

Castleview Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Castleview Partners held 723 positions worth $103M, down 1.9% from $105M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Castleview Partners withdrew a net $6.75M in Q4 2022, closing 93 positions and reducing 96 holdings. Its most notable exit was Genuine Investors ETF, an estimated $3.71M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 61% a quarter earlier, followed by Financials and Technology.

Against the trend, Castleview Partners opened a new position in iShares Russell 1000 Growth ETF worth $1.67M.

  • Castleview Partners's largest Q4 2022 buy was iShares Russell 1000 Growth ETF: 31,136 shares worth $1.67M.
  • Castleview Partners added most to Invesco BulletShares 2024 Corporate Bond ETF in Q4 2022, an estimated $1.14M increase.
  • Castleview Partners's biggest Q4 2022 reduction was State Street SPDR Dow Jones Global Real Estate ETF, cutting an estimated $577K.
  • Castleview Partners fully exited Genuine Investors ETF in Q4 2022, selling an estimated $3.71M.
  • Castleview Partners's ten largest holdings make up 35% of its $103M portfolio in Q4 2022.
  • Castleview Partners opened 84 new positions and closed 93 in Q4 2022.
  • Castleview Partners's portfolio value fell 1.9% quarter-over-quarter to $103M.

Based on Castleview Partners's 13F filing for Q4 2022, filed 1 Feb 2023.